Manipal Health Q1 FY27 Profit Falls Amidst Strong Revenue Growth

Manipal Health Enterprises recorded a 7.48% year-on-year decline in consolidated net profit for Q1 FY27, settling at Rs 231.65 crore. This dip occurred despite the healthcare provider experiencing a substantial 38.12% increase in its revenue from operations.

Q1 FY27 Financial Highlights

• Consolidated Net Profit: Rs 231.65 crore (down 7.48% YoY from Rs 250.37 crore in Q1 FY26)
• Revenue from Operations: Rs 3,090.63 crore (up 38.12% YoY)
• Adjusted PAT (excluding NCD interest for Sahyadri acquisition): 30.9% year-on-year growth
• EBITDA: Rs 749 crore (up 26.4% year-on-year)

Despite the reported decline in headline net profit, the company’s adjusted profit after tax, which excludes interest expenses from non-convertible debentures related to the Sahyadri Hospitals acquisition, demonstrated a robust 30.9% year-on-year growth. EBITDA also saw a significant increase, rising 26.4% to Rs 749 crore.

Operational Performance

• Inpatient Volumes: Surged by 38.8%
• Outpatient Volumes: Increased by 26%
• Occupancy Rate: Improved to 65% (a 290 basis point increase)
• Average Revenue Per Occupied Bed (ARPOB): Rs 71,500 per day

Operational metrics revealed strong performance, with inpatient volumes surging by 38.8% and outpatient volumes up 26% during the quarter. This drove the occupancy rate to 65%, marking a 290 basis point increase from the previous year. Average revenue per occupied bed (ARPOB) also edged higher to Rs 71,500 per day.

Strategic Focus and Growth Drivers

Manipal Health Enterprises, which debuted on the stock market on August 5, 2026, continues to prioritise the integration of Sahyadri Hospitals. This strategic focus aims to leverage a larger network and achieve enhanced operating scale. Key growth drivers included oncology and orthopaedics, with inpatient revenues in these specialities growing by 62% and 49% respectively.